drugset / Trial / NCT00999817
A Pharmacokinetic (PK) Study Of PF-00299804 And Dextromethorphan In Healthy Volunteers
RandomizedCrossoverOpen-labelBasic science
Summary
A study to study the potential effect of PF-00299804 inhibition of CYP2D6 on dextromethorphan.
Timeline
- Start
- 2009-11
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DACOMITINIB ANHYDROUS | Small molecule | 45 mg | Oral |
| Subject | Dextromethorphan | Unknown | 30 mg | Oral |
Indications
No indication recorded.